|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-11-20
|
|
pubmed:abstractText |
Both ACE inhibitors and allopurinol have been shown to partially prevent metabolic syndrome induced by fructose. We tested the hypothesis that combined therapy might be more effective at blocking the metabolic syndrome induced with fructose.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9670
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
399-404
|
|
pubmed:dateRevised |
2010-11-2
|
|
pubmed:meshHeading |
pubmed-meshheading:19696478-Allopurinol,
pubmed-meshheading:19696478-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:19696478-Animal Feed,
pubmed-meshheading:19696478-Animals,
pubmed-meshheading:19696478-Antimetabolites,
pubmed-meshheading:19696478-Body Weight,
pubmed-meshheading:19696478-Captopril,
pubmed-meshheading:19696478-Disease Models, Animal,
pubmed-meshheading:19696478-Drug Synergism,
pubmed-meshheading:19696478-Drug Therapy, Combination,
pubmed-meshheading:19696478-Energy Metabolism,
pubmed-meshheading:19696478-Fructose,
pubmed-meshheading:19696478-Insulin Resistance,
pubmed-meshheading:19696478-Male,
pubmed-meshheading:19696478-Metabolic Syndrome X,
pubmed-meshheading:19696478-Rats,
pubmed-meshheading:19696478-Rats, Sprague-Dawley
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Combination of captopril and allopurinol retards fructose-induced metabolic syndrome.
|
|
pubmed:affiliation |
Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colo., USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
